Global Anti-Infective Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Infective Therapy Market Size 2017-2028

2.1.2 Anti-Infective Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Anti-Infective Therapy Segment by Type

2.2.1 Penicillin

2.2.2 Sulphonamides

2.2.3 Aminoglycosides

2.2.4 Fluoroquinolones

2.2.5 Antifungals

2.2.6 Antiprotozoal

2.2.7 Others

2.3 Anti-Infective Therapy Market Size by Type

2.3.1 Anti-Infective Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Anti-Infective Therapy Market Size Market Share by Type (2017-2022)

2.4 Anti-Infective Therapy Segment by Application

2.4.1 Home User

2.4.2 Hospitals/Clinics

2.4.3 Ambulatory Surgery Centres

2.4.4 Others

2.5 Anti-Infective Therapy Market Size by Application

2.5.1 Anti-Infective Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Anti-Infective Therapy Market Size Market Share by Application (2017-2022)

3 Anti-Infective Therapy Market Size by Player

3.1 Anti-Infective Therapy Market Size Market Share by Players

3.1.1 Global Anti-Infective Therapy Revenue by Players (2020-2022)

3.1.2 Global Anti-Infective Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Anti-Infective Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Anti-Infective Therapy by Regions

4.1 Anti-Infective Therapy Market Size by Regions (2017-2022)

4.2 Americas Anti-Infective Therapy Market Size Growth (2017-2022)

4.3 APAC Anti-Infective Therapy Market Size Growth (2017-2022)

4.4 Europe Anti-Infective Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Anti-Infective Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Anti-Infective Therapy Market Size by Country (2017-2022)

5.2 Americas Anti-Infective Therapy Market Size by Type (2017-2022)

5.3 Americas Anti-Infective Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Infective Therapy Market Size by Region (2017-2022)

6.2 APAC Anti-Infective Therapy Market Size by Type (2017-2022)

6.3 APAC Anti-Infective Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Anti-Infective Therapy by Country (2017-2022)

7.2 Europe Anti-Infective Therapy Market Size by Type (2017-2022)

7.3 Europe Anti-Infective Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Infective Therapy by Region (2017-2022)

8.2 Middle East & Africa Anti-Infective Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Anti-Infective Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Anti-Infective Therapy Market Forecast

10.1 Global Anti-Infective Therapy Forecast by Regions (2023-2028)

10.1.1 Global Anti-Infective Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Anti-Infective Therapy Forecast

10.1.3 APAC Anti-Infective Therapy Forecast

10.1.4 Europe Anti-Infective Therapy Forecast

10.1.5 Middle East & Africa Anti-Infective Therapy Forecast

10.2 Americas Anti-Infective Therapy Forecast by Country (2023-2028)

10.2.1 United States Anti-Infective Therapy Market Forecast

10.2.2 Canada Anti-Infective Therapy Market Forecast

10.2.3 Mexico Anti-Infective Therapy Market Forecast

10.2.4 Brazil Anti-Infective Therapy Market Forecast

10.3 APAC Anti-Infective Therapy Forecast by Region (2023-2028)

10.3.1 China Anti-Infective Therapy Market Forecast

10.3.2 Japan Anti-Infective Therapy Market Forecast

10.3.3 Korea Anti-Infective Therapy Market Forecast

10.3.4 Southeast Asia Anti-Infective Therapy Market Forecast

10.3.5 India Anti-Infective Therapy Market Forecast

10.3.6 Australia Anti-Infective Therapy Market Forecast

10.4 Europe Anti-Infective Therapy Forecast by Country (2023-2028)

10.4.1 Germany Anti-Infective Therapy Market Forecast

10.4.2 France Anti-Infective Therapy Market Forecast

10.4.3 UK Anti-Infective Therapy Market Forecast

10.4.4 Italy Anti-Infective Therapy Market Forecast

10.4.5 Russia Anti-Infective Therapy Market Forecast

10.5 Middle East & Africa Anti-Infective Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Anti-Infective Therapy Market Forecast

10.5.2 South Africa Anti-Infective Therapy Market Forecast

10.5.3 Israel Anti-Infective Therapy Market Forecast

10.5.4 Turkey Anti-Infective Therapy Market Forecast

10.5.5 GCC Countries Anti-Infective Therapy Market Forecast

10.6 Global Anti-Infective Therapy Forecast by Type (2023-2028)

10.7 Global Anti-Infective Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbott Laboratories Ltd.

11.1.1 Abbott Laboratories Ltd. Company Information

11.1.2 Abbott Laboratories Ltd. Anti-Infective Therapy Product Offered

11.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbott Laboratories Ltd. Main Business Overview

11.1.5 Abbott Laboratories Ltd. Latest Developments

11.2 Cipla Ltd.

11.2.1 Cipla Ltd. Company Information

11.2.2 Cipla Ltd. Anti-Infective Therapy Product Offered

11.2.3 Cipla Ltd. Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Cipla Ltd. Main Business Overview

11.2.5 Cipla Ltd. Latest Developments

11.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))

11.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Information

11.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product Offered

11.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Main Business Overview

11.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Latest Developments

11.4 Glenmark Pharmaceuticals Limited

11.4.1 Glenmark Pharmaceuticals Limited Company Information

11.4.2 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product Offered

11.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Glenmark Pharmaceuticals Limited Main Business Overview

11.4.5 Glenmark Pharmaceuticals Limited Latest Developments

11.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)

11.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Information

11.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product Offered

11.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Main Business Overview

11.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Latest Developments

11.6 Lupin Limited

11.6.1 Lupin Limited Company Information

11.6.2 Lupin Limited Anti-Infective Therapy Product Offered

11.6.3 Lupin Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Lupin Limited Main Business Overview

11.6.5 Lupin Limited Latest Developments

11.7 Panacea Biotec Limited

11.7.1 Panacea Biotec Limited Company Information

11.7.2 Panacea Biotec Limited Anti-Infective Therapy Product Offered

11.7.3 Panacea Biotec Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Panacea Biotec Limited Main Business Overview

11.7.5 Panacea Biotec Limited Latest Developments

11.8 Novartis AG

11.8.1 Novartis AG Company Information

11.8.2 Novartis AG Anti-Infective Therapy Product Offered

11.8.3 Novartis AG Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Novartis AG Main Business Overview

11.8.5 Novartis AG Latest Developments

11.9 Pfizer, Inc.

11.9.1 Pfizer, Inc. Company Information

11.9.2 Pfizer, Inc. Anti-Infective Therapy Product Offered

11.9.3 Pfizer, Inc. Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pfizer, Inc. Main Business Overview

11.9.5 Pfizer, Inc. Latest Developments

11.10 Ranbaxy Laboratories Limited

11.10.1 Ranbaxy Laboratories Limited Company Information

11.10.2 Ranbaxy Laboratories Limited Anti-Infective Therapy Product Offered

11.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Ranbaxy Laboratories Limited Main Business Overview

11.10.5 Ranbaxy Laboratories Limited Latest Developments

11.11 Sun Pharmaceutical Industries Limited

11.11.1 Sun Pharmaceutical Industries Limited Company Information

11.11.2 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product Offered

11.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Sun Pharmaceutical Industries Limited Main Business Overview

11.11.5 Sun Pharmaceutical Industries Limited Latest Developments

11.12 AstraZeneca plc

11.12.1 AstraZeneca plc Company Information

11.12.2 AstraZeneca plc Anti-Infective Therapy Product Offered

11.12.3 AstraZeneca plc Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 AstraZeneca plc Main Business Overview

11.12.5 AstraZeneca plc Latest Developments

11.13 Johnson & Johnson

11.13.1 Johnson & Johnson Company Information

11.13.2 Johnson & Johnson Anti-Infective Therapy Product Offered

11.13.3 Johnson & Johnson Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Johnson & Johnson Main Business Overview

11.13.5 Johnson & Johnson Latest Developments

11.14 WOCKHARDT

11.14.1 WOCKHARDT Company Information

11.14.2 WOCKHARDT Anti-Infective Therapy Product Offered

11.14.3 WOCKHARDT Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 WOCKHARDT Main Business Overview

11.14.5 WOCKHARDT Latest Developments

11.15 F. Hoffmann-La Roche Ltd

11.15.1 F. Hoffmann-La Roche Ltd Company Information

11.15.2 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product Offered

11.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.15.5 F. Hoffmann-La Roche Ltd Latest Developments

11.16 Sanofi

11.16.1 Sanofi Company Information

11.16.2 Sanofi Anti-Infective Therapy Product Offered

11.16.3 Sanofi Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Sanofi Main Business Overview

11.16.5 Sanofi Latest Developments

11.17 Merck

11.17.1 Merck Company Information

11.17.2 Merck Anti-Infective Therapy Product Offered

11.17.3 Merck Anti-Infective Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Merck Main Business Overview

11.17.5 Merck Latest Developments

12 Research Findings and Conclusion

Table 1. Anti-Infective Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Penicillin

Table 3. Major Players of Sulphonamides

Table 4. Major Players of Aminoglycosides

Table 5. Major Players of Fluoroquinolones

Table 6. Major Players of Antifungals

Table 7. Major Players of Antiprotozoal

Table 8. Major Players of Others

Table 9. Anti-Infective Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Anti-Infective Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Anti-Infective Therapy Market Size Market Share by Type (2017-2022)

Table 12. Anti-Infective Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Anti-Infective Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Anti-Infective Therapy Market Size Market Share by Application (2017-2022)

Table 15. Global Anti-Infective Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Anti-Infective Therapy Revenue Market Share by Player (2020-2022)

Table 17. Anti-Infective Therapy Key Players Head office and Products Offered

Table 18. Anti-Infective Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Anti-Infective Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Anti-Infective Therapy Market Size Market Share by Regions (2017-2022)

Table 23. Americas Anti-Infective Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Anti-Infective Therapy Market Size Market Share by Country (2017-2022)

Table 25. Americas Anti-Infective Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Anti-Infective Therapy Market Size Market Share by Type (2017-2022)

Table 27. Americas Anti-Infective Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Anti-Infective Therapy Market Size Market Share by Application (2017-2022)

Table 29. APAC Anti-Infective Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Anti-Infective Therapy Market Size Market Share by Region (2017-2022)

Table 31. APAC Anti-Infective Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Anti-Infective Therapy Market Size Market Share by Type (2017-2022)

Table 33. APAC Anti-Infective Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Anti-Infective Therapy Market Size Market Share by Application (2017-2022)

Table 35. Europe Anti-Infective Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Anti-Infective Therapy Market Size Market Share by Country (2017-2022)

Table 37. Europe Anti-Infective Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Anti-Infective Therapy Market Size Market Share by Type (2017-2022)

Table 39. Europe Anti-Infective Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Anti-Infective Therapy Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Anti-Infective Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Anti-Infective Therapy Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Anti-Infective Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Anti-Infective Therapy Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Anti-Infective Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Anti-Infective Therapy Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Anti-Infective Therapy

Table 48. Key Market Challenges & Risks of Anti-Infective Therapy

Table 49. Key Industry Trends of Anti-Infective Therapy

Table 50. Global Anti-Infective Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Anti-Infective Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Anti-Infective Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Anti-Infective Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Anti-Infective Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Anti-Infective Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 56. Abbott Laboratories Ltd. Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 57. Abbott Laboratories Ltd. Anti-Infective Therapy Product Offered

Table 58. Abbott Laboratories Ltd. Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Abbott Laboratories Ltd. Main Business

Table 60. Abbott Laboratories Ltd. Latest Developments

Table 61. Cipla Ltd. Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 62. Cipla Ltd. Anti-Infective Therapy Product Offered

Table 63. Cipla Ltd. Main Business

Table 64. Cipla Ltd. Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Cipla Ltd. Latest Developments

Table 66. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 67. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product Offered

Table 68. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Main Business

Table 69. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Latest Developments

Table 71. Glenmark Pharmaceuticals Limited Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 72. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product Offered

Table 73. Glenmark Pharmaceuticals Limited Main Business

Table 74. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Glenmark Pharmaceuticals Limited Latest Developments

Table 76. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 77. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product Offered

Table 78. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Main Business

Table 79. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Latest Developments

Table 81. Lupin Limited Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 82. Lupin Limited Anti-Infective Therapy Product Offered

Table 83. Lupin Limited Main Business

Table 84. Lupin Limited Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Lupin Limited Latest Developments

Table 86. Panacea Biotec Limited Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 87. Panacea Biotec Limited Anti-Infective Therapy Product Offered

Table 88. Panacea Biotec Limited Main Business

Table 89. Panacea Biotec Limited Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Panacea Biotec Limited Latest Developments

Table 91. Novartis AG Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 92. Novartis AG Anti-Infective Therapy Product Offered

Table 93. Novartis AG Main Business

Table 94. Novartis AG Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Novartis AG Latest Developments

Table 96. Pfizer, Inc. Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 97. Pfizer, Inc. Anti-Infective Therapy Product Offered

Table 98. Pfizer, Inc. Main Business

Table 99. Pfizer, Inc. Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Pfizer, Inc. Latest Developments

Table 101. Ranbaxy Laboratories Limited Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 102. Ranbaxy Laboratories Limited Anti-Infective Therapy Product Offered

Table 103. Ranbaxy Laboratories Limited Main Business

Table 104. Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Ranbaxy Laboratories Limited Latest Developments

Table 106. Sun Pharmaceutical Industries Limited Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 107. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product Offered

Table 108. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 109. Sun Pharmaceutical Industries Limited Main Business

Table 110. Sun Pharmaceutical Industries Limited Latest Developments

Table 111. AstraZeneca plc Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 112. AstraZeneca plc Anti-Infective Therapy Product Offered

Table 113. AstraZeneca plc Main Business

Table 114. AstraZeneca plc Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. AstraZeneca plc Latest Developments

Table 116. Johnson & Johnson Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 117. Johnson & Johnson Anti-Infective Therapy Product Offered

Table 118. Johnson & Johnson Main Business

Table 119. Johnson & Johnson Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Johnson & Johnson Latest Developments

Table 121. WOCKHARDT Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 122. WOCKHARDT Anti-Infective Therapy Product Offered

Table 123. WOCKHARDT Main Business

Table 124. WOCKHARDT Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. WOCKHARDT Latest Developments

Table 126. F. Hoffmann-La Roche Ltd Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 127. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product Offered

Table 128. F. Hoffmann-La Roche Ltd Main Business

Table 129. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. F. Hoffmann-La Roche Ltd Latest Developments

Table 131. Sanofi Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 132. Sanofi Anti-Infective Therapy Product Offered

Table 133. Sanofi Main Business

Table 134. Sanofi Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Sanofi Latest Developments

Table 136. Merck Details, Company Type, Anti-Infective Therapy Area Served and Its Competitors

Table 137. Merck Anti-Infective Therapy Product Offered

Table 138. Merck Main Business

Table 139. Merck Anti-Infective Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. Merck Latest Developments

List of Figures

Figure 1. Anti-Infective Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Anti-Infective Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Anti-Infective Therapy Market Size Market Share by Type in 2021

Figure 7. Anti-Infective Therapy in Home User

Figure 8. Global Anti-Infective Therapy Market: Home User (2017-2022) & ($ Millions)

Figure 9. Anti-Infective Therapy in Hospitals/Clinics

Figure 10. Global Anti-Infective Therapy Market: Hospitals/Clinics (2017-2022) & ($ Millions)

Figure 11. Anti-Infective Therapy in Ambulatory Surgery Centres

Figure 12. Global Anti-Infective Therapy Market: Ambulatory Surgery Centres (2017-2022) & ($ Millions)

Figure 13. Anti-Infective Therapy in Others

Figure 14. Global Anti-Infective Therapy Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Anti-Infective Therapy Market Size Market Share by Application in 2021

Figure 16. Global Anti-Infective Therapy Revenue Market Share by Player in 2021

Figure 17. Global Anti-Infective Therapy Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Anti-Infective Therapy Market Size 2017-2022 ($ Millions)

Figure 19. APAC Anti-Infective Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Europe Anti-Infective Therapy Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Anti-Infective Therapy Market Size 2017-2022 ($ Millions)

Figure 22. Americas Anti-Infective Therapy Value Market Share by Country in 2021

Figure 23. Americas Anti-Infective Therapy Consumption Market Share by Type in 2021

Figure 24. Americas Anti-Infective Therapy Market Size Market Share by Application in 2021

Figure 25. United States Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Anti-Infective Therapy Market Size Market Share by Region in 2021

Figure 30. APAC Anti-Infective Therapy Market Size Market Share by Application in 2021

Figure 31. China Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Anti-Infective Therapy Market Size Market Share by Country in 2021

Figure 38. Europe Anti-Infective Therapy Market Size Market Share by Type in 2021

Figure 39. Europe Anti-Infective Therapy Market Size Market Share by Application in 2021

Figure 40. Germany Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Anti-Infective Therapy Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Anti-Infective Therapy Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Anti-Infective Therapy Market Size Market Share by Application in 2021

Figure 48. Egypt Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Anti-Infective Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 54. APAC Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 55. Europe Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 57. United States Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Canada Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 61. China Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Japan Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Korea Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 65. India Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Australia Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Germany Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 68. France Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 69. UK Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Italy Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Russia Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Spain Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 75. Israel Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Anti-Infective Therapy Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Anti-Infective Therapy Market Size 2023-2028 ($ Millions)